Live
- BJP releases ‘charge sheet’ against BJD govt
- District Nodal Officer Venkataramana announced the intermediate results
- She team that stopped child marriages
- Medical devices sector needs separate rules, says industry body AiMeD
- Andhra Paper declares lockout
- Opposition INDIA bloc working on 'one year, one PM' formula: PM Modi
- Delhi HC quashes FIR for outraging woman's modesty, orders man to assist Traffic Police for a month as settlement
- 'Apologise to families of farmers who committed suicide in Vidarbha', Amit Shah dares Sharad Pawar
- SC Collegium recommends appointment of a permanent judge in Chhattisgarh HC, extension of term of two judges
- U20 Men's football nationals: Telangana, Sikkim earn full points with easy win
Phase-III clinical trial for Covaxin begins at NIMS in Hyderabad
Phase-III clinical trial for Covaxin begins at NIMS in Hyderabad
The Phase-III human clinical trails for Covaxin has begun at Nizam's Institute of Medical Sciences (NIMS) in Hyderabad on Monday.
The Phase-III human clinical trails for Covaxin has begun at Nizam's Institute of Medical Sciences (NIMS) in Hyderabad on Monday. A medical team at NIMS said that the vaccine will be given for 600 volunteers in the phase-III and will be monitored closely.
Phase-I and II trails have said to be successful as no volunteer developed any sign of illness. The Indian Council of Medical Research (ICMR) is planning to bring the vaccine by February. The vaccine is being jointly developed by Bharat Biotech and ICMR.
Bharat Biotech approached Drugs Controller General of India (DCGI) on October 2 for the phase-III trails of Covaxin and the permission was accorded at SEC meeting held in New Delhi on October 19.
The phase-III human trails of Covaxin are being carried out at 19 places including Delhi, Mumbai, Patna, Odisha and Lucknow.
